Acute single non-sedative doses of NOP receptor agonists affect acquisition of object location memory but repeated high doses do not induce long-lasting deficits

Neurobiol Learn Mem. 2023 Nov:205:107841. doi: 10.1016/j.nlm.2023.107841. Epub 2023 Oct 11.

Abstract

The Nociceptin/Orphanin FQ (N/OFQ) system has been shown to modulate various aspects of long-term memory. It is therefore important to study the effects on memory impairment by nociceptin receptor (NOP) agonists under preclinical development. In the present study, we investigated the effect of systemic injection of two small molecule selective NOP agonists, AT-202 and AT-524, in the object location memory task in male and female mice. Since high doses of NOP agonists have been shown to induce sedation, we first determined the sedative doses for the two compounds and found them to be higher in female than in male mice. We then observed that sub-sedative doses of NOP agonists administered before learning, induced memory impairment during a test session performed 24 h later. Again, female mice were less sensitive to the amnesic effects than males. On the contrary, in male mice, NOP agonists did not produce amnesia when they were injected after learning, suggesting that they do not affect the consolidation of object location memory. Finally, repeated administration of high doses of NOP agonists over 7 days did not impair long-term spatial memory. Together, our data show for the first time that NOP receptor agonists impair the acquisition of object location memory with sex-dependent potency but do not affect memory consolidation, and that repeated stimulation of the receptor does not compromise long-term episodic-like spatial memory.

Keywords: Acquisition; NOP receptor; Nociceptin/Orphanin FQ (N/OFQ); Object location memory.

MeSH terms

  • Animals
  • Female
  • Hypnotics and Sedatives
  • Learning
  • Male
  • Memory, Long-Term
  • Mice
  • Nociceptin Receptor
  • Opioid Peptides* / pharmacology
  • Receptors, Opioid*

Substances

  • Receptors, Opioid
  • Opioid Peptides
  • Nociceptin Receptor
  • Hypnotics and Sedatives